Literature DB >> 10651097

Characterisation of Kir2.0 proteins in the rat cerebellum and hippocampus by polyclonal antibodies.

A H Stonehouse1, J H Pringle, R I Norman, P R Stanfield, E C Conley, W J Brammar.   

Abstract

Rabbit polyclonal antibodies were raised to rat Kir2.0 (Kir2.1, Kir2.2 and Kir2.3) inwardly rectifying potassium ion channel proteins. The antibody specificities were confirmed by immunoprecipitation of [35S]-methionine-labelled in vitro translated channel proteins and western blotting. Immunohistochemistry revealed a different patterns of expression of Kir2.0 subfamily proteins in the rat hind-brain (cerebellum and medulla) and fore-brain (hippocampus). Notably, only Kir2.2 protein was detected in the cerebellum and medulla, Kir2.1, Kir2.2 and Kir2.3 proteins were expressed in the hippocampus and immunostaining was not limited to neuronal cell types. Anti-Kir2.1 (fore-brain only) and anti-Kir2.2 (fore- and hind-brain) antibodies showed positive staining in macroglia, endothelia, ependyma and vascular smooth muscle cells. In contrast, anti-Kir2.3 (fore-brain only) immunostaining was limited to neurons, macroglia and vascular smooth muscle. These results indicate that specific regions within the rat fore- and hind-brain have differential distributions of inwardly rectifying potassium ion channel proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10651097     DOI: 10.1007/s004180050429

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  17 in total

1.  Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome.

Authors:  Regina Preisig-Müller; Günter Schlichthörl; Tobias Goerge; Steffen Heinen; Andrea Brüggemann; Sindhu Rajan; Christian Derst; Rüdiger W Veh; Jürgen Daut
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 2.  Molecular substrates of potassium spatial buffering in glial cells.

Authors:  Paulo Kofuji; Nathan C Connors
Journal:  Mol Neurobiol       Date:  2003-10       Impact factor: 5.590

Review 3.  Potassium buffering in the central nervous system.

Authors:  P Kofuji; E A Newman
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

4.  Regulation of a family of inwardly rectifying potassium channels (Kir2) by the m1 muscarinic receptor and the small GTPase Rho.

Authors:  Todd M Rossignol; S V Penelope Jones
Journal:  Pflugers Arch       Date:  2005-11-19       Impact factor: 3.657

5.  Nuclear immunostaining in rat neuronal cells using two anti-Kir2.2 ion channel polyclonal antibodies.

Authors:  Anthony H Stonehouse; Blair D Grubb; J Howard Pringle; Robert I Norman; Peter R Stanfield; William J Brammar
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

Review 6.  Functional implications for Kir4.1 channels in glial biology: from K+ buffering to cell differentiation.

Authors:  Michelle L Olsen; Harald Sontheimer
Journal:  J Neurochem       Date:  2008-08-08       Impact factor: 5.372

7.  Kir4.1-mediated spatial buffering of K(+): experimental challenges in determination of its temporal and quantitative contribution to K(+) clearance in the brain.

Authors:  Brian Roland Larsen; Nanna MacAulay
Journal:  Channels (Austin)       Date:  2014       Impact factor: 2.581

8.  Inward rectifier potassium currents in mammalian skeletal muscle fibres.

Authors:  Marino DiFranco; Carl Yu; Marbella Quiñonez; Julio L Vergara
Journal:  J Physiol       Date:  2015-02-04       Impact factor: 5.182

9.  Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.

Authors:  Richard D Rainbow; Marian James; Diane Hudman; Mohammed Al Johi; Harprit Singh; Peter J Watson; Ian Ashmole; Noel W Davies; David Lodwick; Robert I Norman
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

10.  Pregnenolone sulfate potentiates the inwardly rectifying K channel Kir2.3.

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.